Stuart Roberts is in my opinion Australia's finest analyst in the life sciences sector and whenever we've communicated in the past I've always been impressed with his breadth of knowledge and insight. The 55c price target he ascribes to AHZ is encouraging. It also fits in with my 1 year target of 50c following the groundbreaking results generated in Professor Frazer's Phase I HSV-2 vaccine trial.
updated ballieu report - target range 25-55c, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.69 |
Change
-0.235(4.78%) |
Mkt cap ! $73.33M | |||
| Open | High | Low | Value | Volume |
| $4.94 | $4.94 | $4.69 | $241.6K | 49.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1694 | $4.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.71 | 2000 | 1 |
View Market Depth
| Last trade - 15.59pm 16/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |